Baird Medical Investment Holdings Limited (BDMD) Financial Ratios
6 years of historical data (2019–2024) · Healthcare · Medical - Devices
EV/EBITDA
↑
5.13
↓-32% vs avg
5yr avg: 7.54
30Y Low5.3·High12.6
P/FCF
N/A
—
5yr avg: 18.32
30Y Low18.3·High18.3
P/B Ratio
↓
1.20
↓-81% vs avg
5yr avg: 6.16
30Y Low2.3·High14.6
ROE
↓
33.0%
↑-64% vs avg
5yr avg: 91.1%
30Y Low33%·High201%
Debt/EBITDA
↑
1.24
↑+100% vs avg
5yr avg: 0.62
30Y Low0.2·High4.9
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
BDMD Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Baird Medical Investment Holdings Limited trades at 3.8x earnings, 98% below its 5-year average of 171.5x, sitting at the 0th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a discount of 83%.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Market Cap | $68M | $195M | $81M | $74M | $71M | — | — |
| Enterprise Value | $86M | $213M | $90M | $79M | $71M | — | — |
| P/E Ratio → | 3.80 | 15.51 | 26.12 | 472.81 | — | — | — |
| P/S Ratio | 1.84 | 5.26 | 2.58 | 2.10 | 2.56 | — | — |
| P/B Ratio | 1.20 | 4.90 | 2.27 | 2.86 | 14.62 | — | — |
| P/FCF | — | — | — | — | 18.32 | — | — |
| P/OCF | — | — | — | 151.75 | 13.49 | — | — |
P/E links to full P/E history page with 30-year chart
BDMD EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Baird Medical Investment Holdings Limited's enterprise value stands at 5.1x EBITDA, 32% below its 5-year average of 7.5x. The Healthcare sector median is 14.4x, placing the stock at a 64% discount on an enterprise-value basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 5.74 | 2.85 | 2.26 | 2.55 | — | — |
| EV / EBITDA | 5.13 | 12.64 | 6.96 | 5.26 | 5.31 | — | — |
| EV / EBIT | 5.63 | 14.50 | 7.55 | 5.36 | 5.55 | — | — |
| EV / FCF | — | — | — | — | 18.30 | — | — |
BDMD Profitability
Margins and return-on-capital ratios measuring operating efficiency
Baird Medical Investment Holdings Limited earns an operating margin of 41.4%. Operating margins have expanded from 38.8% to 41.4% over the past 3 years, signaling improving operational efficiency. Return on equity of 33.0% is exceptionally high. ROIC of 22.6% represents excellent returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 88.2% | 88.2% | 86.6% | 79.9% | 83.6% | 86.1% | 89.4% |
| Operating Margin | 41.4% | 41.4% | 37.7% | 38.8% | 43.0% | 54.4% | 45.9% |
| Net Profit Margin | 33.6% | 33.6% | 33.5% | 35.8% | 42.1% | 39.2% | -58.8% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| ROE | 33.0% | 33.0% | 34.3% | 82.1% | 201.1% | 105.0% | — |
| ROA | 18.5% | 18.5% | 21.2% | 36.6% | 54.1% | 49.3% | -61.1% |
| ROIC | 22.6% | 22.6% | 23.5% | 56.4% | 123.4% | 93.1% | 68.5% |
| ROCE | 37.8% | 37.8% | 36.9% | 63.5% | 98.8% | 127.0% | — |
BDMD Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Baird Medical Investment Holdings Limited carries a Debt/EBITDA ratio of 1.2x, which is manageable (62% below the sector average of 3.3x). Net debt stands at $18M ($21M total debt minus $3M cash). Interest coverage of 26.6x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.53 | 0.53 | 0.28 | 0.29 | 0.61 | 0.60 | — |
| Debt / EBITDA | 1.24 | 1.24 | 0.77 | 0.49 | 0.22 | 0.39 | 4.86 |
| Net Debt / Equity | — | 0.45 | 0.23 | 0.22 | -0.02 | 0.44 | — |
| Net Debt / EBITDA | 1.06 | 1.06 | 0.65 | 0.38 | -0.01 | 0.28 | 4.82 |
| Debt / FCF | — | — | — | — | -0.03 | 0.92 | 8.38 |
| Interest Coverage | 26.55 | 26.55 | 41.73 | 45.55 | 77.42 | 61.84 | 62.60 |
BDMD Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.77x means Baird Medical Investment Holdings Limited can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 2.11x to 1.77x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.77 | 1.77 | 2.11 | 2.11 | 2.29 | 1.41 | 0.26 |
| Quick Ratio | 1.74 | 1.74 | 2.05 | 2.03 | 1.98 | 1.32 | 0.24 |
| Cash Ratio | 0.09 | 0.09 | 0.09 | 0.12 | 0.35 | 0.12 | 0.01 |
| Asset Turnover | — | 0.48 | 0.55 | 0.82 | 1.06 | 1.06 | 1.04 |
| Inventory Turnover | 3.38 | 3.38 | 3.70 | 5.45 | 1.49 | 3.10 | 1.83 |
| Days Sales Outstanding | — | 459.03 | 365.42 | 257.58 | 163.89 | 165.78 | 136.28 |
BDMD Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Baird Medical Investment Holdings Limited does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 26.3% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | 7.7% | — | — |
| Payout Ratio | — | — | — | — | 46.5% | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | 26.3% | 6.4% | 3.8% | 0.2% | — | — | — |
| FCF Yield | — | — | — | — | 5.5% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 7.7% | — | — |
| Shares Outstanding | — | $26M | $8M | $7M | $7M | $7M | $7M |
Peer Comparison
Compare BDMD with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 BDMDYou | $68M | 3.8 | 5.1 | — | 88.2% | 41.4% | 33.0% | 22.6% | 1.2 |
 NVCR | $2B | -13.8 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 ARAY | $35M | -18.9 | 11.0 | — | 32.1% | 1.7% | -2.5% | 3.0% | 12.6 |
 AEYE | $100M | -32.4 | — | — | 78.3% | -7.9% | -43.2% | -42.4% | — |
 ELMD | $222M | 31.2 | 19.1 | 20.1 | 78.1% | 15.1% | 17.2% | 25.6% | 0.0 |
 HLIT | $1B | 37.2 | 18.9 | 26.1 | 53.9% | 9.3% | 8.7% | 9.3% | 2.0 |
 IRTC | $4B | -89.8 | — | 118.8 | 70.6% | -4.9% | -36.6% | -5.2% | — |
 INVA | $2B | 6.9 | 8.1 | 9.9 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 MDT | $100B | 21.6 | 14.3 | 19.3 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 BSX | $84B | 29.2 | 25.3 | 23.0 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 SYK | $113B | 35.0 | 20.3 | 26.3 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 6 years · Updated daily
See BDMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BDMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BDMD vs NVCR
Side-by-side business, growth, and profitability comparison vs NovoCure Limited.
Start ComparisonBDMD — Frequently Asked Questions
Quick answers to the most common questions about buying BDMD stock.
What is Baird Medical Investment Holdings Limited's P/E ratio?
Baird Medical Investment Holdings Limited's current P/E ratio is 3.8x. The historical average is 20.8x.
What is Baird Medical Investment Holdings Limited's EV/EBITDA?
Baird Medical Investment Holdings Limited's current EV/EBITDA is 5.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 7.5x.
What is Baird Medical Investment Holdings Limited's ROE?
Baird Medical Investment Holdings Limited's return on equity (ROE) is 33.0%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 91.1%.
Is BDMD stock overvalued?
Based on historical data, Baird Medical Investment Holdings Limited is trading at a P/E of 3.8x. Compare with industry peers and growth rates for a complete picture.
What are Baird Medical Investment Holdings Limited's profit margins?
Baird Medical Investment Holdings Limited has 88.2% gross margin and 41.4% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
How much debt does Baird Medical Investment Holdings Limited have?
Baird Medical Investment Holdings Limited's Debt/EBITDA ratio is 1.2x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.